Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles

References

• Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, Rota M, Corrao G, Garavello W, Schuz J et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer J Int Du Cancer 2011; 129:2473-84; PMID:21190191; http://dx.doi.org/10.1002/ijc.25885
   PubMed Web of Science ®Google Scholar
• Tramacere I, Negri E, Bagnardi V, Garavello W, Rota M, Scotti L, Islami F, Corrao G, Boffetta P, La Vecchia C. A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: overall results and dose-risk relation. Oral Oncol 2010; 46:497-503; PMID:20444641; http://dx.doi.org/10.1016/j.oraloncology.2010.03.024
   PubMed Web of Science ®Google Scholar
• Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, Sowka M, Golusinski P, Malicki J, Golusinski W. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol 2014; 48:1-10; PMID:24587773; http://dx.doi.org/10.2478/raon-2013-0057
   PubMed Web of Science ®Google Scholar
• Fakhry C, Psyrri A, Chaturvedhi A. HPV and head and neck cancers: state-of-the-science. Oral Oncol 2014; 50:353-5; PMID:24726207; http://dx.doi.org/10.1016/j.oraloncology.2014.03.010
   PubMed Web of Science ®Google Scholar
• Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision making in the management of recurrent head and neck cancer. Head Neck 2014; 36:144-51; PMID:23471843; http://dx.doi.org/10.1002/hed.23227
   PubMed Web of Science ®Google Scholar
• Lescaille G, Pitoiset F, Macedo R, Baillou C, Huret C, Klatzmann D, Tartour E, Lemoine FM, Bellier B. Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers. Human Gene Therapy 2013; 24:533-44; PMID:23521528; http://dx.doi.org/10.1089/hum.2012.037
   PubMed Web of Science ®Google Scholar
• Nizard M, Diniz MO, Roussel H, Tran T, Ferreira LC, Badoual C, Tartour E. Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites. Hum Vaccin Immunother 2014; 10:2175-87; PMID:25424921; http://dx.doi.org/10.4161/hv.29269
   PubMed Web of Science ®Google Scholar
• Usui S, Urano M, Koike S, Kobayashi Y. Effect of PS-K, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma. J Natl Cancer Inst 1976; 56:185-7; PMID:130494
   PubMedGoogle Scholar
• Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G et al. Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors. Sci Translational Med 2013; 5:172ra20; PMID:23408053; http://dx.doi.org/10.1126/scitranslmed.3004888
   PubMed Web of Science ®Google Scholar
• Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CP, Yong CS, Pegram HJ, Stacker SA, Achen MG et al. Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy. Mol Therapy 2014; 22:18-27; PMID:24048441; http://dx.doi.org/10.1038/mt.2013.219
   PubMed Web of Science ®Google Scholar
• Green VL, Michno A, Stafford ND, Greenman J. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunol Immunotherapy 2013; 62:863-73; PMID:23359088; http://dx.doi.org/10.1007/s00262-013-1395-9
   PubMed Web of Science ®Google Scholar
• Wansom D, Light E, Thomas D, Worden F, Prince M, Urba S, Chepeha D, Kumar B, Cordell K, Eisbruch A et al. Infiltrating lymphocytes and human papillomavirus-16–associated oropharyngeal cancer. Laryngoscope 2012; 122:121-7; PMID:22183632; http://dx.doi.org/10.1002/lary.22133
   PubMed Web of Science ®Google Scholar
• Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol 2014; 51:90-5; PMID:25283344; http://dx.doi.org/10.1016/j.oraloncology.2014.09.006
   PubMed Web of Science ®Google Scholar
• Wallis SP, Stafford ND, Greenman J. Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck 2014; 37:449-59; PMID:24803283; http://dx.doi.org/10.1002/hed.23736
   PubMed Web of Science ®Google Scholar
• McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov 2013; 12:217-28; PMID:23449307; http://dx.doi.org/10.1038/nrd3870
   PubMed Web of Science ®Google Scholar
• Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 2004; 10:301-13; PMID:14734483; http://dx.doi.org/10.1158/1078-0432.CCR-0999-3
   PubMed Web of Science ®Google Scholar
• Raimondi AR, Molinolo A, Gutkind JS. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 2009; 69:4159-66; PMID:19435901; http://dx.doi.org/10.1158/0008-5472.CAN-08-4645
   PubMed Web of Science ®Google Scholar
• Cui N, Nomura T, Noma H, Yokoo K, Takagi R, Hashimoto S, Okamoto M, Sato M, Yu G, Guo C et al. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 2005; 11:2713-9; PMID:15814653; http://dx.doi.org/10.1158/1078-0432.CCR-04-1767
   PubMed Web of Science ®Google Scholar
• Vahle AK, Hermann S, Schafers M, Wildner M, Kerem A, Ozturk E, Jure-Kunkel M, Franklin C, Lang S, Brandau S. Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy. Head Neck 2016; 38(4):542-9; PMID:25482887; http://dx.doi.org/10.1002/hed.23929
   PubMed Web of Science ®Google Scholar
• Paolini F, Massa S, Manni I, Franconi R, Venuti A. Immunotherapy in new pre-clinical models of HPV-associated oral cancers. Hum Vaccin Immunother 2013; 9:534-43; PMID:23296123; http://dx.doi.org/10.4161/hv.23232
   PubMed Web of Science ®Google Scholar
• Mondini M, Nizard M, Tran T, Mauge L, Loi M, Clemenson C, Dugue D, Maroun P, Louvet E, Adam J et al. Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer. Mol Cancer Therapeutics 2015; 14:1336-45; PMID:25833837; http://dx.doi.org/10.1158/1535-7163.MCT-14-1015
   PubMed Web of Science ®Google Scholar
• Bozec A, Sudaka A, Toussan N, Fischel JL, Etienne-Grimaldi MC, Milano G. Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model. Annals Oncol 2009; 20:1703-7; PMID:19542251; http://dx.doi.org/10.1093/annonc/mdp070
   PubMed Web of Science ®Google Scholar
• Yang K, Zhao N, Zhao D, Chen D, Li Y. The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day. Drug Des Devel Ther 2013; 7:511-7; PMID:23818762; http://dx.doi.org/10.2147/DDDT.S46323
   PubMed Web of Science ®Google Scholar
• Torrieri-Dramard L, Lambrecht B, Ferreira HL, Van den Berg T, Klatzmann D, Bellier B. Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses. Mol Therapy 2011; 19:602-11; PMID:20959813; http://dx.doi.org/10.1038/mt.2010.222
   PubMed Web of Science ®Google Scholar
• Mascarell L, Zimmer A, Van Overtvelt L, Tourdot S, Moingeon P. Induction of allergen-specific tolerance via mucosal routes. Curr Top Microbiol Immunol 2011; 352:85-105; PMID:21562971; http://dx.doi.org/10.1007/82_2011_132
   PubMed Web of Science ®Google Scholar
• Appledorn DM, Aldhamen YA, Godbehere S, Seregin SS, Amalfitano A. Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunity. Clin Vaccine Immunol 2011; 18:150-60; PMID:21084461; http://dx.doi.org/10.1128/CVI.00341-10
   PubMed Web of Science ®Google Scholar
• Choi JH, Schafer SC, Zhang L, Kobinger GP, Juelich T, Freiberg AN, Croyle MA. A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs. Mol Pharm 2012; 9:156-67; PMID:22149096; http://dx.doi.org/10.1021/mp200392g
   PubMed Web of Science ®Google Scholar
• Domm W, Brooks L, Chung HL, Feng C, Bowers WJ, Watson G, McGrath JL, Dewhurst S. Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier. Vaccine 2011; 29:7080-9; PMID:21801777; http://dx.doi.org/10.1016/j.vaccine.2011.07.008
   PubMed Web of Science ®Google Scholar
• Park HJ, Ferko B, Byun YH, Song JH, Han GY, Roethl E, Egorov A, Muster T, Seong B, Kweon MN et al. Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice. PloS one 2012; 7:e39921; PMID:22761928; http://dx.doi.org/10.1371/journal.pone.0039921
   PubMed Web of Science ®Google Scholar
• Singh S, Yang G, Schluns KS, Anthony SM, Sastry KJ. Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge. PloS one 2014; 9:e90001; PMID:24599269; http://dx.doi.org/10.1371/journal.pone.0090001
   PubMedGoogle Scholar
• Etchart N, Desmoulins PO, Chemin K, Maliszewski C, Dubois B, Wild F, Kaiserlian D. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J Immunol 2001; 167:384-91; PMID:11418674; http://dx.doi.org/10.4049/jimmunol.167.1.384
   PubMed Web of Science ®Google Scholar
• Kichaev G, Mendoza JM, Amante D, Smith TR, McCoy JR, Sardesai NY, Broderick KE. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses. Hum Vaccin Immunother 2013; 9:2041-8; PMID:23954979; http://dx.doi.org/10.4161/hv.25272
   PubMed Web of Science ®Google Scholar
• Desvignes C, Esteves F, Etchart N, Bella C, Czerkinsky C, Kaiserlian D. The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo. Clin Exp Immunol 1998; 113:386-93; PMID:9737667; http://dx.doi.org/10.1046/j.1365-2249.1998.00671.x
   PubMed Web of Science ®Google Scholar
• Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, Novak N. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63:720-7; PMID:18445186; http://dx.doi.org/10.1111/j.1398-9995.2007.01611.x
   PubMed Web of Science ®Google Scholar
• Hervouet C, Luci C, Bekri S, Juhel T, Bihl F, Braud VM, Czerkinsky C, Anjuere F. Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells. Mucosal Immunol 2014; 7:280-91; PMID:23801305; http://dx.doi.org/10.1038/mi.2013.45
   PubMed Web of Science ®Google Scholar
• Sun YY, Peng S, Han L, Qiu J, Song L, Tsai YC, Yang B, Roden RB, Trimble CL, Hung CF et al. Local HPV recombinant Vaccinia boost following priming with an HPV DNA vaccine enhances local HPV-specific CD8+ T cell mediated tumor control in the genital tract. Clin Cancer Res 2013; 22(3):657-69; PMID:26420854; http://dx.doi.org/10.1158/1078-0432.CCR-15-0234
   PubMed Web of Science ®Google Scholar
• Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, Spagnoli G, Ritter G, Hoffmann TK, Knuth A et al. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer. Int J Cancer J Int Du Cancer 2015; 135:1142-52; PMID:24482145; http://dx.doi.org/10.1002/ijc.28752
   Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008
   PubMed Web of Science ®Google Scholar
• Perez-Gracia JL, Labiano S, Rodriguez-Ruiz ME, Sanmamed MF, Melero I. Orchestrating immune check-point blockade for cancer immunotherapy in combinations. Curr Opin Immunol 2014; 27:89-97; PMID:24485523; http://dx.doi.org/10.1016/j.coi.2014.01.002
   PubMed Web of Science ®Google Scholar
• Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 2013; 73:128-38; PMID:23135914; http://dx.doi.org/10.1158/0008-5472.CAN-12-2606
   PubMed Web of Science ®Google Scholar